Sahrun S, Wulandari L. Case report: Management of Progressive Lung Cancer Patients after First-Line EGFR Tyrosine Kinase Inhibitor Therapy. FMI [Internet]. 2019 Oct. 3 [cited 2024 Nov. 28];55(3):239-45. Available from: https://e-journal.unair.ac.id/FMI/article/view/15509